Showing results (131-140 of 159) with videos related to
Sort By:
Pageof 16
Annals of the Rheumatic Diseases|September 5, 2015
Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathwayElena López-Isac, Diana Campillo-Davo, Lara Bossini-Castillo, et al.The Journal of Rheumatology|July 3, 2017
An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic SclerosisLara Bossini-Castillo, Diana Campillo-Davó, Elena López-Isac, et al.Plos One|February 2, 2013
The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosisF David Carmona, Jose-Ezequiel Martin, Lorenzo Beretta, et al.Annals of the Rheumatic Diseases|August 17, 2012
TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patientsEugénie Koumakis, Julien Wipff, Philippe Dieudé, et al.Journal of the American Heart Association|February 26, 2025
Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research CohortAndrea-Hermina Györfi, Tim Filla, Amin Polzin, et al.Plos Genetics|July 14, 2011
Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosisYannick Allanore, Mohamad Saad, Philippe Dieudé, et al.Arthritis Research & Therapy|January 10, 2014
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibilityElena López-Isac, Lara Bossini-Castillo, Carmen P Simeon, et al.RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.Annals of the Rheumatic Diseases|December 13, 2016
Update of EULAR recommendations for the treatment of systemic sclerosisOtylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, et al.Clinical and Experimental Rheumatology|August 29, 2015
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosisEguzkine Ochoa, José-Ezequiel Martin, Shervin Assasi, et al.Pageof 16